Icosavax Inc

NASDAQ:ICVX   2:14:33 PM EDT
27.08
+1.11 (+4.27%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.07B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.6 Million
Adjusted EPS-$0.49
See more estimates
10-Day MA$31.99
50-Day MAN/A
200-Day MAN/A
See more pivots

Icosavax Inc Stock, NASDAQ:ICVX

1616 Eastlake Avenue East, Suite 208, Seattle, Washington 98102
United States of America
Phone: +1.206.737.0085
Number of Employees:

Description

Icosavax, Inc. engages in the development and commercialization of vaccines against infectious diseases. It focuses in developing vaccine candidates for viral causes of pneumonia in older adults. The company was founded by Neil King and David Baker on November 1, 2017 and is headquartered in Seattle, WA.